Hello my name is Xavier Palomer.  I am the CEO of Psious.
We do Virtual Reality for mental health care.
As you probably know, a lot of people are suffering from different anxiety
related disorders.
Such as fear of flying.
At Psious we have therapists to treat these patients
by exposing them to different
virtual reality experiences controlled
by the therapist.  And you have to think about it
that mental health care
has a lot of social stigma behind it.
People don't like to talk about these things.
And in our case, our patients they
post about this technology.
They talk about different issues in the social networks
with their friends.  So you can imagine the difference
being from social stigma, past
to this technology, where they post
on the social networks about this.  They talk about this.
The difference is incredible.
So why Founders Factory?
We are from Spain. We started our business in Spain
and we are growing quite significantly in Spain.
We decided few months ago to start our
international expansion, and
we think and we really believe that Founders Factory is the perfect partner
to start expanding within the UK market
and grow internationally.
So today we have, we can help patients with
more than 15 different disorders.
Mostly related to anxiety.
But where we see the business growing
is expanding into the different mental health areas.
Like pain distraction intensity,
which we are already conducting clinical trials on that.
So the areas to expand the business within
the health care space.
In the long-term our bed is Data.  We are collecting,
today we have database with more than
4000 patients.  So you can imagine
that our database is
one of the biggest today in the world.
Relating anxiety treatments and patients, and different
processes they have been through, and the response they had.
We really believe, we strongly believe that
within the long-term that's going to be an important
asset for the company.
For the  to understand anxiety, to understand treatment
and they are there to have better outcomes or better treatments
for patients.
